CJPRY (CJPRY) Stock Price & Analysis
CJPRY (CJPRY) rose 2.77% to USD 11.87 as of July 25, 2026 at 03:49 UTC, according to Nexqual real-time market data.
CJPRY last closed at USD 11.55; the session ranged USD 11.86–11.87 on volume of 4,421 shares. Market capitalization is $22.58B, with a 52-week range of USD 10.03–15.68 (PNK). Source: Nexqual, July 25, 2026 at 03:49 UTC.
Key Statistics (as of July 25, 2026 at 03:49 UTC)
| Price | USD 11.87 |
|---|---|
| Change | ▲ 2.77% (up) |
| Previous Close | USD 11.55 |
| Open | USD 11.86 |
| Day Range | USD 11.86 – 11.87 |
| 52-Week Range | USD 10.03 – 15.68 |
| Volume | 4,421 shares |
| Market Cap | $22.58B |
| Exchange | PNK |
Technical Analysis (CJPRY)
Nexqual's technical model rates CJPRY "BUY" based on 5 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 03:49 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 68.9 (neutral) |
| vs SMA50 | Above (USD 10.91) |
| MACD | 0.24 (positive) |
Analyst Ratings (CJPRY)
Wall Street analysts rate CJPRY "None", per Nexqual as of July 25, 2026 at 03:49 UTC.
| Consensus Rating | None |
|---|
Earnings (CJPRY)
| Next Earnings Date | 2026-07-31 |
|---|---|
| Revenue Estimate | $471.81B |
Source: Nexqual, July 25, 2026 at 03:49 UTC.
Financials & Fundamentals (CJPRY)
| Total Revenue | $2.01T |
|---|---|
| Revenue Growth (YoY) | +6.10% |
| Gross Margin | +52.19% |
| Operating Margin | +27.11% |
| Profit Margin | +27.56% |
| ROE | +11.47% |
| Debt / Equity | 83.87 |
| Current Ratio | 1.8 |
| Total Cash | $368.59B |
| Total Debt | $4.31T |
| Free Cash Flow | $419.00B |
Source: Nexqual, July 25, 2026 at 03:49 UTC.
Financial Health Score (CJPRY)
Nexqual rates CJPRY's overall financial health "Solid" across five dimensions, as of July 25, 2026 at 03:49 UTC.
| Growth | Solid — Revenue +10% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 52%, operating 27% |
| Balance Sheet | Mixed — $368.6B cash vs $4.31T debt |
| Cash Flow | Strong — FCF $419.0B, 21% margin |
| Efficiency | Mixed — ROE 11%, ROA 4.9% |
Ownership (CJPRY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.01% |
| Shares Outstanding | 1.90B |
| Float | 1.88B |
Source: Nexqual, July 25, 2026 at 03:49 UTC.
Leadership (CJPRY)
CJPRY is led by Shunsuke Niwa (age 60), President & Representative Director, per Nexqual as of July 25, 2026 at 03:49 UTC.
| President & Representative Director | Shunsuke Niwa (age 60) |
|---|---|
| Executive VP & Representative Director | Takanori Mizuno (age 67) |
| Executive VP & Representative Director | Atsushi Tsujimura (age 60) |
| Executive VP & Representative Director | Kentaro Takeda (age 57) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| EJPRY | East Japan Railway Co. | USD 11.1 | ▲ 0.54% |
| WJRYY | West Japan Railway Co. | USD 18.22 | ▲ 1.45% |
| CHGCY | Chugai Pharmaceutical Co., Ltd. | USD 21.87 | ▼ 2.15% |
| SHECY | Shin-Etsu Chemical Co., Ltd. | USD 18.49 | ▼ 14.67% |
| SOMLY | Secom Co., Ltd. | USD 10.39 | ▲ 1.17% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:49 UTC. This page is informational and not investment advice.